Form 4 for ALKS Alkermes plc.
Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-09 · accession 0001127602-24-028885 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-09 | 2024-12-09 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $22.70 | +49.0K | 72.2K | +211% | +$1.11M |
| D | 2024-12-09 | 2024-12-09 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | S - Sale+OE | $32.07 | -61.2K | 47.6K | -56% | -$1.96M |
| DM | 2024-12-09 | 2024-12-09 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $0.00 | -49.0K | 116.7K | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-12-09 | M | A | 12,411 | $26.82 | 108,727 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-12-09 | S | D | 61,151 | $32.07 | 47,576 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.2514. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. |
| 3 | Common | Ordinary Shares | 2024-12-09 | M | A | 12,044 | $24.59 | 96,316 | D | — | — | |
| 4 | Common | Ordinary Shares | 2024-12-09 | M | A | 12,090 | $19.34 | 84,272 | D | — | — | |
| 5 | Common | Ordinary Shares | 2024-12-09 | M | A | 12,452 | $20.03 | 72,182 | D | — | — | |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2024-12-09 | M | D | 12,411 | $0.00 | 110,616 | D | $26.82 · — to 2033-02-23 | 12,411 Ordinary Shares | (F7) Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2024-12-09 | M | D | 12,044 | $0.00 | 130,300 | D | $24.59 · — to 2032-02-18 | 12,044 Ordinary Shares | (F6) Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2024-12-09 | M | D | 12,090 | $0.00 | 188,323 | D | $19.34 · — to 2031-02-22 | 12,090 Ordinary Shares | (F5) Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2024-12-09 | M | D | 12,452 | $0.00 | 116,722 | D | $20.03 · — to 2030-02-20 | 12,452 Ordinary Shares | (F4) These options are fully vested in accordance with their terms. |